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LETTER TO THE EDITORS
To the Editors:
Patients undergoing orthotopic liver transplanta-
tion (OLT) for such diseases as primary biliary
cirrhosis (PBC) or autoimmune hepatitis (AIH)
have an immune disorder that predominantly tar-
gets the liver. There is no reason to believe that
replacement of the target organ would modify that
process, except by the concomitant administration
of immunosuppressive agents.
Hayashi et al1 have shown a higher incidence of
acute cellular rejection (ACR) in patients with AIH
and PBC. Similarly, Berlakovich et al2 reported a
59% incidence of ACR in patients with PBC com-
pared with 38% in patients with alcoholic liver
disease (P , .02). In her series, death from sepsis
occurred in 26% of the patients with PBC com-
pared with 11% of the patients with alcoholic liver
disease. In a retrospective analysis of liver biopsies
performed specifically to rule out ACR, we found
ACR in 10 of 57 patients (18%) with alcoholic liver
disease compared with 11 of 19 patients (58%)
with PBC (P , .005) or 9 of 12 patients (75%;
P , .005) with primary sclerosing cholangitis
(PSC).
These findings are not, however, reflected in the
National Institute of Diabetes and Digestive and
Kidney Diseases database (R.H. Wiesner, personal
communication, November 1996). This could be
the result of pooling observations from several
centers with different diagnostic criteria and differ-
ent indications for liver biopsy. When we tried to
show an association between the incidence of ACR
and the percentage of diagnoses reported as PBC,
PSC, and AIH using the references reported in our
publication,3 we were able to establish a correla-
tion, although it did not reach statistical signifi-
cance (P , .1). This is not surprising because of
the inclusion of up to 30% of patients diagnosed as
‘‘other’’ in some series and the apparent absence of
AIH as a diagnosis from virtually all the publica-
tions.
Patients who undergo OLT are biologically het-
erogeneous and may therefore require different
immunosuppression postoperatively. As these regi-
mens are re-examined and revised downward, it
may be useful to examine the outcome stratified by
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